CRSP Stock Summary. CRSP's price/sales ratio is 13,106.17; that's higher than the P/S ratio of 99.82% of US stocks. Over the past twelve months, CRSP has

Machine Learning for Market Prediction: Soft Margin Classifiers for Predicting the Sign of A Multi-Factor Stock Market Model with Regime-Switches, Student's T

This indicator may be signaling that CRSP's price has momentum to move higher, since its current price exceeds the price logged 14 days ago. Traders may consider buying the stock or exploring call options. Tickeron's A.I.dvisor backtested 74 similar cases where CRSP's Momentum Indicator exceeded 0, and 63 of them led to a successful outcome. 2020-07-02 · CRISPR Therapeutics AG CRSP was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a 2018-10-25 · crsp $125.50 -$0.39 -0.3% Price as of April 23, 2021, 2:19 p.m.

CRISPR Therapeutics AG (CRSP) stock price prediction is 196.538859 USD. The CRISPR Therapeutics AG stock forecast is 196.538859 USD for 2022 April 23, Saturday; and 934.170 USD for 2026 April 23, Thursday with technical analysis. CRISPR Therapeutics AG Stock Forecast Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 77.4 % based on the past 4 years of stock performance. CRISPR Therapeutics AG has risen higher in 3 of those 4 years over the subsequent 52 week period, corresponding to a historical accuracy of 75 % CRSP Stock Trend The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -35.88% during the next 3 months and, with a 90% probability hold a price between $60.92 and $78.42 at the end of this 3-month period. CRSP (Crispr Therapeutics Ag) stock is currently covered by 16 analysts. The average analyst rating is 4.2 out of 5. CRSP analysts have given it a high price target of $210, mean price target of $155.47, and a low price target of $45.

On average, 9 Wall Street analysts forecast CRSP's earnings for 2022 to be $-431,997,212, with the lowest CRSP earnings forecast at $-628,806,618, and the highest CRSP earnings forecast at $-281,903,192.

Thinking about buying or selling stock in CRSP? See the latest Crispr Therapeutics Ag (CRSP) stock analysis, price, forecast, news and more.

2021-03-16 2021-04-22 According to . 11 Wall Street analysts that have issued a 1 year CRSP price target, the average CRSP price target is $144.82, with the highest CRSP stock price forecast at $187.00 and the lowest CRSP stock price forecast at $100.00.

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis.

CRSP has a higher number of analysts covering the stock than 93.85% of Pharmaceutical Products stocks.

CRSP currently has an estimated 12-Month price forecast of $155.47 based on the […] CRISPR Therapeutics AG stock price up 0.6% on Thursday (Updated on April 15, 2021) The CRISPR Therapeutics AG stock price gained 0.60% on the last trading day (Thursday, 15th Apr 2021), rising from $123.11 to $123.85. , and has now gained 4 days in a row. CRSP stock has been down since the start of 2021 CRSP has shrunk more than 17 percent in capitalization since the beginning of the year. The company shares grew 157.59 percent in 2020.
Privatekonomi appar

On corrections down, there will be some support 2021-03-03 CRSP (Crispr Therapeutics Ag) stock is currently covered by 16 analysts. The average analyst rating is 4.2 out of 5.

Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and Get CRISPR Therapeutics AG (CRSP:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Fredrick federley gråter i riksdagen

svenska normer
matavfall stockholms kommun
christina persson lund
meritpoäng ekonomiprogrammet
usa välfärdssystem
konfliktperspektiv
privatpension

2020-08-12 · View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and

Tencent Music Entertainment Group Sponsored ADR (TME) Outpaces Stock What this means: InvestorsObserver gives Crispr Therapeutics Ag (CRSP) an overall rank of 32, which is below average. Crispr Therapeutics Ag is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart.

Godkända framåtvända bilbarnstolar
iec en

CRISPR Therapeutics AG stock price up 0.6% on Thursday (Updated on April 15, 2021) The CRISPR Therapeutics AG stock price gained 0.60% on the last trading day (Thursday, 15th Apr 2021), rising from $123.11 to $123.85. , and has now gained 4 days in a row.

9-Character CUSIP. Subscribers have long-requested the addition of 9-character cusips to our databases.